← Evidence map

ArticleClinical case reports2021

Successful ixazomib treatment for relapsed and refractory acute myeloid leukemia transformed from myelodysplastic syndrome.

Satoko Oka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34194792